๐Ÿ’ฐ 2026 Funding Top 10 Rounds

2026 Medical Device Funding Rounds

The biggest capital raises shaping the medical device industry in 2026 โ€” $3.8B tracked across 32 rounds

Total Capital Raised
$3.8B
Across all tracked rounds
Rounds Tracked
32
YTD 2026
Avg Round Size
$119M
Up 24% vs 2025
Top Category
Surgical Robotics
Leading by deal count
Top 10 Funding Rounds 2026 YTD
Ranked by round size
# Company Device / Technology Stage Amount Lead Investor Date Category Signal Ticker Device Page
1
HNS Neurostimulator
Hypoglossal Nerve Stim (HNS) Series F $200M OrbiMed May 2, 2026 Neurostimulation ๐Ÿ”ฅ Hot NYSE: INSP
loading...
View Device โ†’
2
ClotTriever System
ClotTriever Thrombectomy Series E $185M Deerfield Apr 30, 2026 Cardiovascular ๐Ÿ”ฅ Hot Private View Device โ†’
3
Tablo Hemodialysis
Tablo Hemodialysis Console Series E $180M OrbiMed Feb 14, 2026 Renal โœ… Strong NASDAQ: OM
loading...
View Device โ†’
4
iQ3 Ultrasound
iQ3 Handheld Ultrasound Series D $150M Gates/Fosun Apr 18, 2026 Imaging โœ… Strong NYSE: BFLY
loading...
View Device โ†’
5
iLet Bionic Pancreas
iLet Bionic Pancreas Series E $120M Novo Holdings Apr 14, 2026 Diabetes ๐Ÿ”ฅ Hot Private View Device โ†’
6
VR Surgical Robot
VR-Assisted Surgical Robot Series C $110M General Catalyst Apr 28, 2026 Surgical Robotics ๐Ÿ”ฅ Hot Private View Device โ†’
7
HF10 Therapy
HF10 Spinal Cord Stim Series D $110M Deerfield Jan 28, 2026 Neuromodulation โœ… Strong Private Site โ†’
8
Miniaturized SCS
Miniaturized Spinal Cord Stim Series D $95M OrbiMed Apr 10, 2026 Neuromodulation ๐Ÿ‘ Watch Private View Device โ†’
9
Evoke Closed-Loop SCS
Evoke Closed-Loop SCS Series D $90M Cowen Healthcare Apr 6, 2026 Neuromodulation ๐Ÿ‘ Watch Private View Device โ†’
10
OMNI Surgical System
OMNI Glaucoma System Series D $65M NEA Jan 8, 2026 Ophthalmology ๐Ÿ‘ Watch Private Site โ†’

Investor Leaderboard

Top 5 by Capital Deployed
#1 Investor
Deerfield Management
$440M
7 deals ยท Healthcare specialist
#2 Investor
OrbiMed
$385M
3 deals ยท MedTech focused
#3 Investor
Novo Holdings
$170M
2 deals ยท Diabetes expertise
#4 Investor
General Catalyst
$110M
1 deal ยท Robotics focus
#5 Investor
DCVC Bio
$45M
1 deal ยท Deep tech bio

Funding by Category

2026 YTD
๐Ÿ’“ Cardiovascular
$365M
Largest category ยท 4 rounds
๐Ÿฉธ Diabetes
$320M
Post-PMA momentum ยท 3 rounds
๐Ÿง  Neuromodulation
$295M
SCS dominance ยท 4 rounds
๐Ÿค– Surgical Robotics
$280M
FDA submissions incoming ยท 3 rounds